Concurrence of Membranous Glomerulonephritis and Pulmonary Alveolar Proteinosis
暂无分享,去创建一个
Y. Kim | K. Jin | B. Park | Tae-hoon No | Hyun-Kuk Kim | Min-Gyo Seo | Yeon Mee Kim
[1] Y. Nasuhara,et al. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. , 2010, American journal of respiratory and critical care medicine.
[2] H. Debiec,et al. Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy. , 2010, Journal of the American Society of Nephrology : JASN.
[3] David M. Beck,et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.
[4] J. Seymour,et al. Pulmonary alveolar proteinosis: progress in the first 44 years. , 2002, American journal of respiratory and critical care medicine.
[5] J. Watanabe,et al. Idiopathic Pulmonary Alveolar Proteinosis as an Autoimmune Disease with Neutralizing Antibody against Granulocyte/Macrophage Colony-Stimulating Factor , 1999, The Journal of experimental medicine.
[6] H. Colten,et al. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. , 1993, The New England journal of medicine.
[7] W. Kitagawa,et al. Membranous nephropathy and pulmonary alveolar proteinosis. , 2007, Internal medicine.